Skip to main content

Kodumudi V, Rosenthal A, Conde G, et al.
Dermatologic Surgery (2025)

JC: October 2025

This study examined how postoperative defect size should guide reconstruction planning decisions after Mohs surgery. The analysis provided evidence-based criteria for selecting among closure methods (primary, flap, graft, second intention) based on final defect dimensions and anatomic location.

Take-Home Messages

  • Postoperative defect size is a key determinant of reconstruction method selection and should be systematically assessed after Mohs surgery.
  • Evidence-based defect size thresholds can help standardize reconstruction decision-making and improve surgical outcomes.

Topic

Reconstruction

Flaps, grafts, wound closure techniques after Mohs

Related MohsPedia Articles

Abstract

Brigham and Women's Hospital (BWH) criteria classify cutaneous squamous cell carcinoma (cSCC) with a preoperative (clinical) size ≥2 cm as high risk. However, the role of postoperative defect (histologic) size after Mohs micrographic surgery (MMS) in cSCC staging remains unclear. To compare outcomes of cSCCs treated with MMS that have a clinical size <2 cm but a histologic size ≥2 cm with those clinically ≥2 cm. Data were collected at a tertiary academic center. Patien...

Literature review only. This summary is an editorial interpretation and may not reflect the complete findings of the original publication. Always refer to the full-text article for clinical decision-making.